Renaissance Technologies »

Brainstorm Cell Therapeutics shares owned by Renaissance Technologies

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Renaissance Technologies from 13F filings

Historical chart of Renaissance Technologies investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Renaissance Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Renaissance Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $41k 204k 0.20
2023-06-30 $426k 207k 2.06
2022-12-31 $19k 12k 1.61
2022-09-30 $246k 56k 4.42
2022-06-30 $47k 17k 2.75
2021-06-30 $181k 48k 3.80
2020-12-31 $124k 27k 4.53
2020-06-30 $1.6M 141k 11.21
2020-03-31 $2.7M 577k 4.64
2019-12-31 $1.4M 334k 4.28
2019-09-30 $1.2M 297k 3.90
2019-06-30 $886k 224k 3.95
2019-03-31 $880k 203k 4.34
2018-12-31 $648k 183k 3.55
2018-09-30 $512k 134k 3.82
2018-06-30 $450k 115k 3.90
2018-03-31 $281k 89k 3.15
2017-12-31 $449k 115k 3.92
2017-09-30 $95k 23k 4.12